LAIR1 and neoplasm: The C1q complement molecule has the ability to bind and activate LAIR-1 to evade immune responses and expression of several members of the collagen family, such as collagens I, III, V, VI, XIII, XVII, XVIII, and XXIII [23] is reported to be associated with tumour progression [24,25].